Announcements Trials
Browse Landscape

Status

Completed 607Terminated 140Recruiting 132Unknown 123Active not recruiting 38Not yet recruiting 37Withdrawn 31Enrolling by invitation 9Suspended 4No longer available 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 15Lymphoid 13Tumor-Agnostic 12Other hematologic neoplasm 12Gastrointestinal 12Thoracic 11Sarcoma 11Genitourinary 11Myeloid 7Breast 7Plasma cell 6Gynecologic 6Head & Neck 5Dermatologic 5Endocrine 4Other solid neoplasm 2NET 1Classical hematology 1

Conditions

Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1Hematologic Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1Adrenoleukodystrophy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Classical hematology × Clear all
NCT01881334 2025-11-20

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Duke University

Available
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adrenoleukodystrophy, Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡